BMS 100 852 (Sprycel 100 mg)
Generic Name: dasatinib
Pill imprint BMS 100 852 has been identified as Sprycel 100 mg.
Sprycel is used in the treatment of chronic myelogenous leukemia; leukemia; acute lymphoblastic leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 100 852 (Sprycel 100 mg)
Sprycel
- Generic Name:
- dasatinib
- Imprint:
-
BMS 100
852 - Strength:
- 100 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-0852
- Inactive Ingredients:
- croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
More resources
Sprycel is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
